Basic Information
ID: ALA4825256
Type: Functional
Description: Antiviral activity against SARS-CoV-2 nCoV-2019BetaCoV/Wuhan/WIV04/ infected in African green monkey Vero E6 cells assessed as inhibition of viral replication at 10 uM when host cells were pretreated for 1 hr followed by viral infection then followed by removal of infected supernatant and subsequent culture addition with fresh compounds and measured after 24 hrs by qRT-PCR method relative to control
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Strain: nCoV-2019BetaCoV/Wuhan/WIV04/
Cell type: Vero E6
Target: SARS-CoV-2(ALA4303835)
Document: ALA4823313
Antiviral activity against SARS-CoV-2 nCoV-2019BetaCoV/Wuhan/WIV04/ infected in African green monkey Vero E6 cells assessed as inhibition of viral replication at 10 uM when host cells were pretreated for 1 hr followed by viral infection then followed by removal of infected supernatant and subsequent culture addition with fresh compounds and measured after 24 hrs by qRT-PCR method relative to control: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4825256
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 309.26 | -1.72 | -1.72 |
| 405.41 | 0.30 | 0.30 |
| 620.57 | 2.45 | 2.45 |